FibroGen, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() AGIO
Agios Pharmaceuticals, Inc. |
$25.97 | $1.48 B | 2.23 | 486 |
![]() AKRO
Akero Therapeutics, Inc. |
$35.99 | $2.87 B | -9.6 | 63 |
![]() ARDX
Ardelyx, Inc. |
$4.46 | $1.06 B | -26.24 | 395 |
![]() AVRO
AVROBIO, Inc. |
$1.40 | $5.24 M | 0.17 | 13 |
![]() BMEA
Biomea Fusion, Inc. |
$2.00 | $75.14 M | -0.52 | 106 |
![]() BMRN
BioMarin Pharmaceutical Inc. |
$59.17 | $11.29 B | 26.77 | 3040 |
![]() BPMC
Blueprint Medicines Corporation |
$80.27 | $5.13 B | -75.02 | 649 |
![]() CGEM
Cullinan Oncology, Inc. |
$7.25 | $424.22 M | -2.61 | 111 |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$7.02 | $711.51 M | -6.88 | 181 |
![]() FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$4.06 | $249.42 M | -4.14 | 134 |
![]() GOSS
Gossamer Bio, Inc. |
$0.85 | $193.16 M | -3.4 | 144 |
![]() HEPA
Hepion Pharmaceuticals, Inc. |
$0.42 | $451,440 | 0 | 22 |
![]() LRMR
Larimar Therapeutics, Inc. |
$1.87 | $119.41 M | -1.41 | 65 |
![]() LYEL
Lyell Immunopharma, Inc. |
$0.45 | $132.82 M | -0.34 | 300 |
![]() MREO
Mereo BioPharma Group plc |
$1.83 | $283.92 M | -6.1 | 36 |
![]() MRUS
Merus N.V. |
$37.40 | $2.58 B | -11.16 | 260 |
![]() PCVX
Vaxcyte, Inc. |
$32.51 | $4.19 B | -8.56 | 414 |
![]() RVMD
Revolution Medicines, Inc. |
$31.40 | $5.84 B | -8.77 | 534 |
![]() SNDX
Syndax Pharmaceuticals, Inc. |
$11.01 | $947.34 M | -2.96 | 270 |
![]() STOK
Stoke Therapeutics, Inc. |
$6.00 | $317.80 M | -3.64 | 128 |
![]() STRO
Sutro Biopharma, Inc. |
$0.71 | $59.44 M | -0.24 | 310 |
![]() THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 |
![]() VSTM
Verastem, Inc. |
$5.10 | $262.32 M | -1.39 | 78 |
![]() ZURA
Zura Bio Limited |
$1.15 | $78.63 M | -1.92 | 30 |